

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 1, 26 | Mora Elizabeth | director | S-Sale | 300 @ $250.96 | $75.29K |
| Aug 17, 26 | Donlan Renee Martel | officer: EVP, GC & CCO | A-Award | 954 | — |
| Aug 14, 26 | Lee John Tseng-Chung | director, officer: President & CEO | S-Sale | 10,000 @ $302.01 | $3.02M |
| Aug 3, 26 | Williams John Edward | officer: EVP & GM, PSD | S-Sale | 457 @ $288.31 | $131.8K |
| Jun 12, 26 | Schreiner James Alan | officer: EVP & COO | S-Sale | 2,471 @ $345.52 | $853.8K |
| Jun 12, 26 | Schreiner James Alan | officer: EVP & COO | S-Sale | 812 @ $346.41 | $281.3K |
| Jun 12, 26 | Schreiner James Alan | officer: EVP & COO | S-Sale | 217 @ $347.00 | $75.30K |
| Jun 10, 26 | Schreiner James Alan | officer: EVP & COO | S-Sale | 781 @ $317.42 | $247.9K |
| 4 | Aug 17, 2026 | 2026-08-17 10:11:54 | View |
| 10-Q | Aug 6, 2026 | 2026-08-06 15:30:56 | View |
| 8-K | Aug 5, 2026 | 2026-08-05 16:31:16 | View |
| 4 | Aug 4, 2026 | 2026-08-04 12:21:52 | View |
| SC 13G/A | Jul 24, 2026 | 2026-07-24 15:21:15 | View |
| SC 13G | Jul 16, 2026 | 2026-07-16 16:07:25 | View |
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
DUTCH ASSET Corp acquired a new position in MKS Inc. (NASDAQ: MKSI) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 2,530 shares of the scientific and technical instruments company's stock, valued at approximately $672,000. Several other institutional investors
ANDOVER, Mass., Oct. 19, 2026 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that it has entered into a definitive agreement to sell its Ophir® Optics business to TTM Technologies, Inc. (“TTM”) in an all-cash transaction for $650 million, subject to customary closing adjustments. The purchase price represents an estimated multiple of over 18x projected FY 2026 Adjusted EBITDA for the Ophir Optics business.
Assenagon Asset Management S.A. grew its holdings in shares of MKS Inc. (NASDAQ: MKSI) by 1,742.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 442,273 shares of the scientific and technical instruments company's stock after buying an additional
MKS (MKSI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors looking for stocks in the Electronics - Miscellaneous Products sector might want to consider either MKS (MKSI) or Rockwell Automation (ROK). But which of these two stocks is more attractive to value investors?
The consensus price target hints at a 60.3% upside potential for MKS (MKSI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | 2.91 | 3.30 | Beat 13.4% | $1.25B |
| May 6, 2026 | 2.04 | 2.30 | Beat 12.7% | $1.08B |
| Feb 17, 2026 | 2.46 | 2.47 | Beat 0.4% | $1.03B |
| Nov 5, 2025 | 1.85 | 1.93 | Beat 4.3% | $988.0M |
| Aug 6, 2025 | 1.61 | 1.77 | Beat 9.9% | $973.0M |
| May 7, 2025 | 1.42 | 1.71 | Beat 20.4% | $936.0M |
Annual filings (FY) with consensus forward estimates (hatched)
Current price $196.55
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 17, 26 | Morgan Stanley | maintain | Overweight | Overweight |
| Aug 25, 26 | Mizuho | maintain | Outperform | Outperform |
| Aug 7, 26 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Aug 7, 26 | JP Morgan | maintain | Overweight | Overweight |
| Aug 7, 26 | Citigroup | maintain | Buy | Buy |
| Aug 6, 26 | Needham | maintain | Buy | Buy |
| Aug 3, 26 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Aug 3, 26 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Jul 24, 26 | Citigroup | maintain | Buy | Buy |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 25.49 | Oscillator | Buy |
| Stochastic %K (14, 3, 3) | 6.97 | Oscillator | Buy |
| Williams %R (14) | -95.19 | Oscillator | Buy |
| MACD (12, 26, 9) | -16.91 (Hist -5.70) | Oscillator | Strong Sell |
| Average Directional Index (14) | 32.10 (+DI 11.5 / -DI 42.5) | Trend | Strong Sell |
| EMA 20 | 234.68 | MA | Strong Sell |
| SMA 20 | 245.54 | MA | Strong Sell |
| EMA 50 | 257.51 | MA | Strong Sell |
| SMA 50 | 256.94 | MA | Strong Sell |
| SMA 200 | 277.55 | MA | Strong Sell |
TTM vs. 5-year historical average (annual ratios)
| Metric | MKSI | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 30.1x | 20.5x · sector 44.2x | Discount |
| Forward P/E (FY26E) | 15.0x | EPS est. 13.15 | Discount |
| Price / Book | 4.4x | 2.8x | Elevated |
| Price / Sales | 3.1x | 2.3x | Elevated |
| EV / EBITDA | 16.5x | 8.7x | Elevated |
| Return on equity | 15.8% | — | Healthy |
| Gross margin | 44.1% | 44.8% | In line |
| Debt / Equity | 1.40 | 1.47 | Moderate |
| Piotroski / Altman Z | 7/9 | Z 2.27 | Grey zone |
Discounted cash flow model